Potassium-Restricted Diet for Hyperkalemia
(EvoKe-HD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method for managing hyperkalemia, a condition characterized by excessive potassium in the blood. Instead of eliminating all high-potassium foods, the focus is on avoiding foods with easily absorbed potassium, such as processed meats and certain drinks. This novel dietary approach is compared to the traditional method. Participants are divided into two groups: one avoids these specific foods, while the other reduces high-potassium foods overall. Suitable candidates for this trial include those on dialysis three times a week who have experienced high potassium levels before treatments. As an unphased trial, this study provides a unique opportunity to explore innovative dietary management strategies for hyperkalemia.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on dietary changes for managing hyperkalemia.
What prior data suggests that this dietary approach is safe for managing hyperkalemia?
Research has shown that high potassium intake can sometimes increase the risk of hyperkalemia in people with chronic kidney disease (CKD). For this reason, doctors often recommend reducing foods high in potassium. However, some studies have found no link between dietary potassium intake and blood potassium levels, suggesting that consuming potassium-rich foods might not always lead to elevated potassium levels in the body.
While specific safety studies on this new dietary approach are lacking, it generally remains safe for most people since it involves dietary changes. Avoiding foods like processed meats and sugary drinks may even provide additional health benefits. It is important to consult a healthcare provider before making significant dietary changes, especially if other health issues are present.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a fresh dietary approach to managing hyperkalemia, a condition characterized by high potassium levels in the blood. Unlike traditional methods that simply cut down on foods with high total potassium, this new approach focuses on restricting foods with highly bioavailable potassium, such as those with potassium additives and certain animal products. This could offer a more targeted way to manage potassium levels by reducing the intake of potassium that is more readily absorbed by the body. The trial aims to determine if this method is more effective and easier for patients to follow compared to conventional dietary restrictions.
What evidence suggests that this trial's dietary approaches could be effective for hyperkalemia?
Studies have shown that controlling potassium intake is crucial for individuals with high potassium levels, particularly those with chronic kidney disease (CKD). In this trial, participants will follow one of two dietary approaches. The traditional approach reduces foods high in total potassium content, such as fruits and vegetables. The novel dietary approach, assigned to some participants, avoids foods where potassium is easily absorbed, including those with additives, processed meats, milk, and sugary drinks. Research indicates that this method may better manage potassium levels. Although more research is needed, this approach could offer a promising way to improve health for people with high potassium levels.678910
Are You a Good Fit for This Trial?
This trial is for adults who speak French or English, have had at least two high potassium blood tests in the last 3 months, and regularly attend hemodialysis sessions. It's not for those with limited control over their diet, a life expectancy under six months, or significant cognitive issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive dietary counseling to manage potassium intake, with monthly meetings with a renal dietitian
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Novel dietary approach focused on restricting the intake of highly bioavailable potassium
- Traditional approach
Trial Overview
The EvoKe-HD study is testing a new dietary method to manage high potassium levels by limiting foods with easily absorbed potassium versus the traditional approach of avoiding high-potassium whole foods.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will be asked to identify and avoid food items with potassium additives by revising the ingredient lists of the grocery products they consume. They will also be asked to reduce two sources of high bioavailability potassium, such as meat, milk, fruit juices, processed potatoes or coffee.
Participants will be asked to reduce the intake of food items with high total potassium content. A list of moderate-to-high potassium food items will be provided to the participants.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
Published Research Related to This Trial
Citations
New Insights Into Dietary Approaches to Potassium ...
Potassium disorders are one of the most common electrolyte abnormalities in patients with chronic kidney disease (CKD), contributing to poor clinical outcomes.
Evaluating the Effectiveness of a Generative Pretrained ...
This study aims to evaluate the effectiveness of a dietary recommendation system driven by generative pretrained transformers (GPTs) in managing potassium ...
Potassium-Restricted Diet for Hyperkalemia (EvoKe-HD Trial)
EvoKe-HD is a pilot randomized controlled trial to assess the feasibility and potential for efficacy of a novel dietary approach to hyperkalemia.
Potassium Disorders: Hypokalemia and Hyperkalemia
A low-potassium diet is generally recommended for patients with advanced CKD (Table 2). More research is needed for dietary potassium restriction in CKD.
Effect of Dietary Potassium Restriction on Serum ...
Very-low-quality evidence supports consensus that dietary potassium restriction reduces Sk in normokalemia but whether this is associated with risk of death in ...
Impact of Dietary Potassium Restrictions in CKD on Clinical ...
There are data suggesting that high-potassium intake increases the risk for hyperkalemia in some patients with CKD, and current recommendations and guidelines ...
Re-Thinking Hyperkalaemia Management in Chronic ...
Lower dietary potassium intake was associated with higher risk of death (HR 2.65, 95% CI 1.40–5.04) in fully adjusted model comparing lowest ...
New Insights Into Dietary Approaches to Potassium ...
In this study, the researchers found no association of dietary potassium intake with serum potassium levels, with prevalence of hyperkalemia, or ...
Overview of research progress on the association of dietary ...
This study showed no association between serum potassium and dietary potassium intake in the low potassium intake(≤3000 mg/d) and high potassium intake(>3000 mg ...
Associations Between Dietary Potassium Intake From ...
This study investigated the association between potassium intake from different food sources and hyperkalemia in patients with non-dialysis-dependent CKD.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.